GB201417248D0 - Compostion and methods of treatment - Google Patents

Compostion and methods of treatment

Info

Publication number
GB201417248D0
GB201417248D0 GBGB1417248.0A GB201417248A GB201417248D0 GB 201417248 D0 GB201417248 D0 GB 201417248D0 GB 201417248 A GB201417248 A GB 201417248A GB 201417248 D0 GB201417248 D0 GB 201417248D0
Authority
GB
United Kingdom
Prior art keywords
compostion
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1417248.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Blueberry Therapeutics Ltd
Original Assignee
Blueberry Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blueberry Therapeutics Ltd filed Critical Blueberry Therapeutics Ltd
Priority to GBGB1417248.0A priority Critical patent/GB201417248D0/en
Publication of GB201417248D0 publication Critical patent/GB201417248D0/en
Priority to PCT/GB2015/052866 priority patent/WO2016051179A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/88—Polyamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm
GBGB1417248.0A 2014-09-30 2014-09-30 Compostion and methods of treatment Ceased GB201417248D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1417248.0A GB201417248D0 (en) 2014-09-30 2014-09-30 Compostion and methods of treatment
PCT/GB2015/052866 WO2016051179A1 (en) 2014-09-30 2015-09-30 Composition comprising lactoferrine and methods of treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1417248.0A GB201417248D0 (en) 2014-09-30 2014-09-30 Compostion and methods of treatment

Publications (1)

Publication Number Publication Date
GB201417248D0 true GB201417248D0 (en) 2014-11-12

Family

ID=51901364

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1417248.0A Ceased GB201417248D0 (en) 2014-09-30 2014-09-30 Compostion and methods of treatment

Country Status (2)

Country Link
GB (1) GB201417248D0 (en)
WO (1) WO2016051179A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201810925D0 (en) * 2018-07-03 2018-08-15 Blueberry Therapeutics Ltd Compositions and methods of treatment
GB201810923D0 (en) * 2018-07-03 2018-08-15 Blueberry Therapeutics Ltd Compositions and method of treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2646777B1 (en) * 1989-05-12 1993-09-03 Bio Serae Lab PROCESS FOR PREPARING AN ANTIMICROBIAL PARTICULATE PRODUCT, ANTIMICROBIAL PRODUCT OBTAINED AND APPLICATIONS
JP5633953B2 (en) * 2006-01-31 2014-12-03 コヴィディエン リミテッド パートナーシップ Super flexible foam
US9770419B2 (en) * 2012-08-01 2017-09-26 Shaker A. Mousa Methods and compositions of camel derived products

Also Published As

Publication number Publication date
WO2016051179A1 (en) 2016-04-07

Similar Documents

Publication Publication Date Title
IL286316A (en) Novel micro-dystrophins and related methods of use
IL259783A (en) Methods of treatment of malignancies
IL250415B (en) Anti-pdl- antibodies and methods of use thereof
GB201701673D0 (en) Methods of well treatment
HK1253049A1 (en) Glycan-interacting compounds and methods of use
GB201502084D0 (en) Catheter devices and related methods
IL251988A0 (en) Glycan-interacting compounds and methods of use
IL282482A (en) Protoxin-ii variants and methods of use
IL282508A (en) Protoxin-ii variants and methods of use
RS60718B1 (en) Compounds and methods of use
GB201410116D0 (en) Method of treatment
EP3134108A4 (en) Agents and methods of treatment
GB201416832D0 (en) Methods of treatment
IL253028B (en) Method of treatment
ZA201606450B (en) Compounds and their methods of use
HK1249866A1 (en) Methods of treatment with taselisib
GB201511799D0 (en) Composition and methods of treatment
GB201417248D0 (en) Compostion and methods of treatment
GB201412010D0 (en) Treatment of hypertransaminasemia
GB201512139D0 (en) Methods of treatment
GB201403697D0 (en) Compounds and methods of use
GB201416797D0 (en) Contianer and method of use thereof
AU2014901480A0 (en) Agents and methods of treatment
GB201421980D0 (en) Method of treatment
GB201421982D0 (en) Method of treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)